Oct 7 (Reuters) - Intellipharmaceutics International Inc I.TO
* Says received tentative approval from u.s. Fda for co's new drug application for quetiapine fumarate
* Launch of its generic versions of seroquel xr is subject to fda final approval of co's anda
* Intellipharmaceutics announces fda tentative approval for generic seroquel xr
* Intellipharmaceutics announces fda tentative approval for generic seroquel xr
* Pursuant to settlement between co & astrazeneca in 2012, co is permitted to launch generic versions of seroquel xr on nov 1 2016 Source text for Eikon: ID:nGNXNHITDa Further company coverage: I.TO